Pathogenesis, epidemiology and control of Group A Streptococcus infection

S Brouwer, T Rivera-Hernandez, BF Curren… - Nature Reviews …, 2023 - nature.com
Abstract Streptococcus pyogenes (Group A Streptococcus; GAS) is exquisitely adapted to
the human host, resulting in asymptomatic infection, pharyngitis, pyoderma, scarlet fever or …

Glomerulonephritis: immunopathogenesis and immunotherapy

HJ Anders, AR Kitching, N Leung… - Nature Reviews …, 2023 - nature.com
Abstract 'Glomerulonephritis'(GN) is a term used to describe a group of heterogeneous
immune-mediated disorders characterized by inflammation of the filtration units of the kidney …

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA

MR Davies, N Keller, S Brouwer, MG Jespersen… - Nature …, 2023 - nature.com
A new variant of Streptococcus pyogenes serotype M1 (designated 'M1UK') has been
reported in the United Kingdom, linked with seasonal scarlet fever surges, marked increase …

Antibiotic resistance: a global crisis, problems and solutions

R Aggarwal, P Mahajan, S Pandiya… - Critical Reviews in …, 2024 - Taylor & Francis
Healthy state is priority in today's world which can be achieved using effective medicines.
But due to overuse and misuse of antibiotics, a menace of resistance has increased in …

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population

DL Wagner, L Amini, DJ Wendering, LM Burkhardt… - Nature medicine, 2019 - nature.com
The discovery of the highly efficient site-specific nuclease system CRISPR–Cas9 from
Streptococcus pyogenes has galvanized the field of gene therapy,. The immunogenicity of …

A global view of pulmonary hypertension

MM Hoeper, M Humbert, R Souza, M Idrees… - The Lancet …, 2016 - thelancet.com
Pulmonary hypertension is a substantial global health issue. All age groups are affected with
rapidly growing importance in elderly people, particularly in countries with ageing …

Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management

SYC Tong, JS Davis, E Eichenberger… - Clinical microbiology …, 2015 - journals.asm.org
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

The cGAS-STING pathway: a promising immunotherapy target

L Ou, A Zhang, Y Cheng, Y Chen - Frontiers in immunology, 2021 - frontiersin.org
With the continuous development of immunotherapy, researchers have paid more attention
to the specific immune regulatory mechanisms of various immune responses in different …

Global and regional patterns in cardiovascular mortality from 1990 to 2013

GA Roth, MD Huffman, AE Moran, V Feigin… - Circulation, 2015 - ahajournals.org
There is a global commitment to reduce premature cardiovascular diseases (CVDs) 25% by
2025. CVD mortality rates have declined dramatically over the past 2 decades, yet the …